A new study finds a strong link between gastroesophageal symptoms and higher rheumatoid arthritis (RA) disease activity, highlighting the need for symptom monitoring in RA management.
Gastroesophageal symptoms significantly impact methotrexate dosages and disease activity among patients with RA.
Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback